Nanobacteria: Facts or fancies?

PLoS Pathogens

Volumn 3, Issue 5, 2007, Pages 0567-0570

  Urbano, Pasquale ^a,b   Urbano, Francesco ^c,d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Public Health ^*  (Italy)

^c Logistic Headquarters   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM; BACTERIUM CULTURE; CELL FREE SYSTEM; CULTURE MEDIUM; DISEASE ASSOCIATION; HUMAN; IMMUNOGENICITY; INFECTION RISK; MINERALIZATION; NANOBACTERIUM; NONHUMAN; NOTE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 34249743109     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0030055     Document Type: Note

References (42)

1. Kajander EO, Ciftcioglu N (1998) Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95: 8274-8279.
2. US Securities and Exchange Commission (2006) Nanobac Pharmaceuticals Inc. annual report (form 10-KSB). Available: http://www.secinfo.com/d12TC3.vCSq.htm (page 3). Accessed 19 April 2007.
3. Barr SC, Linke RA, Janssen D, Guard CL, Smith MC Daugherty CS, et al. (2003) Detection of biofilm formation and nanobacteria under long-term cell culture conditions in serum samples of cattle, goats, cats, and dogs. Am J Vet Res 64: 176-182.
4. Breitschwerdt EB, Sontakke S, Cannedy A, Hancock SI, Bradley JM (2001) Infection with Bartonella weissii and detection of Nanobacterium antigens in a North Carolina beef herd. J Clin Microbiol 39: 879-882.
5. Wang XJ, Liu W, Yang ZL, Wei H, Wen Y, et al. (2004) The detection of nanobacteria infection in serum of healthy Chinese people. Zhonghua Liu Xing Bing Xue Za Zhi 25: 492-494.
6. Li Y, Wen Y, Yang Z, Wei H, Liu W, et al. (2002) Culture and identification of nanobacteria in bile. Zhonghua Yi Xue Za Zhi 82: 1557-1560.
7. Ciftcioglu N, Kajander EO (1998) Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4: 259-270.
8. Kim BH, Park HS, Kim HJ, Kim GT, Chang IS, et al. (2004) Enrichment of microbial community generating electricity using a fuel-cell-type electrochemical cell. Appl Microbiol Biotechnol 63: 672-681.
9. Wainwright M, Weber PK, Smith JB, Hutcheon ID, Klyce B, et al. (2004) Studies on bacteria-like particles sampled from the stratosphere. Aerobiologia 20: 237-240.
10. Benzerara K, Menguy N, Guyot F, Dominici C, Gillet P (2003) Nanobacteria-like calcite single crystals at the surface of the Tataouine meteorite. Proc Natl Acad Sci U S A 100: 7438-7442.
11. Ciftcioglu N, Björklund M, Kuorikoski K, Bergstrom K, Kajander EO (1999) Nanobacteria: An infectious cause for kidney stone formation. Kidney Int 56: 1893-1898.
12. Kajander EO, Ciftcioglu N, Aho K, Garcia-Cuerpo E (2003) Characteristics of nanobacteria and their possible role in stone formation. Urol Res 31: 47-54.
13. Shiekh FA, Khullar M, Singh SK (2006) Lithogenesis: Induction of renal calcifications by nanobacteria. Urol Res 34: 53-57.
14. Khullar M, Sharma SK, Singh SK, Bajwa P, Sheikh FA, et al. (2004) Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 32: 190-195.
15. Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, et al. (2005) Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 118: 421-424.
16. Puskaìs LG, Tiszlavicz L, Raìzga Zs, Torday LL, Krenaìcs T, et al. (2005) Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56: 233-245.
17. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, et al. (2004) Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287: H1115-H1124.
18. Jelic TM, Malas AM, Groves SS, Jin B, Mellen PF, et al. (2004) Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 97: 194-198.
19. Hudelist G, Singer CF, Kubista E, Manavi M, Mueller R, et al. (2004) Presence of nanobacteria in psammoma bodies of ovarian cancer: Evidence for pathogenetic role in intratumoral biomineralization. Histopathology 45: 633-637.
20. Altundag K, Altundag O, Akyurek S, Atik MA (2006) Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J 12: 287.
21. Gundeslioglu O, Altundag O, Altundag K (2005) Nanobacteria and breast implant capsule contracture and calcification: A hypothesis. Aesthet Plast Surg 29: 582.
22. Tsurumoto T, Matsumoto T, Yonekura A, Shindo H (2006) Nanobacteria-like particles in human arthritic synovial fluids. J Proteome Res 5: 1276-1278.
23. Shoskes DA, Thomas KD, Gomez E (2005) Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: Preliminary experience. J Urol 173: 474-477.
24. Ciftcioglu N, McKay DS, Kajander EO (2003) Association between nanobacteria and periodontal disease. Circulation 108: 8.
25. Eskandary H, Saba M, Yazdi T (2005) Nanobacteria and intervertebral disc degeneration. Med Hypotheses 65: 997-998.
26. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, et al. (2000) Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57: 2360-2374.
27. Kajander EO, Ciftcioglu N, Miller-Hjelle MA, Hjelle JT (2001) Nanobacteria: Controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr Opin Nephrol Hypertens 10: 445-452.
28. Sommer AP (2004) Could reduced bone mineral densities in HIV be caused by nanobacteria? J Proteome Res 3: 670-672.
29. Sommer AP (2003) Peripheral neuropathy and light - Preliminary report indicating prevalence of nanobacteria in HIV. J Proteome Res 2: 665-666.
30. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, et al. (2000) An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A 97: 11511-11515.
31. Drancourt M, Jacomo V, Lépidi H, Lechevallier E, Grisoni V, et al. (2003) Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol 41: 368-372.
32. Kajander EO, Kuronen I, Akerman KK, Pelttari A, Ciftcioglu N (1997) Fine nanobacteria from blood: The smallest culturable autonomously replicating agent on Earth. In: Hoover RB, editor. Conference 3111: Instruments, methods, and missions for the investigation of extraterrestrial microorganisms; 29 July-1 August 1997; San Diego, California. Proc SPIE 3111: 420-428.
33. Maniloff J, Nealson KH, Psenner R, Loferer M, Folk RL (1997) Nannobacteria: Size limits and evidence. Science 276: 1773-1776.
34. Mushegian AR, Koonin EV (1996) A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc Natl Acad Sci U S A 93: 10268-10273.
35. Knoll A (1998) Size limits of very small microorganisms - Overview. Available: http://books.nap.edu//html/ssb_html/NANO/nanooverview.shtml. Accessed 19 April 2007.
36. Aho K, Kajander EO, Raoult D (2003) Pitfalls in detection of novel nanoorganisms. J Clin Microbiol 41: 3460-3461.
37. Wainwright M (1999) Nanobacteria and associated 'elementary bodies' in human disease and cancer. Microbiology 145: 10.
38. Kajander EO (2006) Nanobacteria - Propagating calcifying nanoparticles. Lett Appl Microbiol 42: 549-552.
39. Travis J (1998) The bacteria in the stone. Science News 154: 75.
40. Kajander EO, Tahvanainen E, Kuronen I, Ciftcioglu N (1994) Comparison of Staphylococci and novel bacteria-like particles from blood. Zbl Bakt (Suppl) 26: 147-149.
41. Maniscalco BS, Taylor KA (2004) Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11: 95-101.
42. Ciftcioglu N, Haddad RS, Golden DC, Morrison DR, McKay DS (2005) A potential cause for kidney stone formation during space flights: Enhanced growth of nanobacteria in microgravity. Kidney Int 67: 483-491.